Reviva Pharmaceuticals (NASDAQ:RVPH) (NASDAQ: RVPH) is a U.S.–based specialty pharmaceutical company focused on the acquisition, development and commercialization of prescription products for the dermatology and aesthetic medicine markets. The company leverages a combination of in-house formulation expertise and strategic licensing partnerships to bring novel topical and oral therapies to physicians and patients grappling with conditions such as hyperhidrosis, acne, rosacea and post-surgical wound care. Reviva’s business model emphasizes targeted niche brands that benefit from streamlined regulatory paths and dedicated medical education programs.
Reviva’s commercial portfolio includes both self-marketed products and assets out-licensed to larger pharmaceutical partners. The company’s in-house commercial team works closely with specialty pharmacies, dermatology clinics and aesthetic medicine providers to support patient access, reimbursement and professional training. Reviva also maintains active R&D collaborations aimed at expanding its pipeline through new molecular entities and improved drug‐delivery technologies, such as micro-emulsion systems and bio-adhesive gels designed to enhance topical penetration.
Founded in 1993 and headquartered in Coral Gables, Florida, Reviva has built a global footprint through selective licensing agreements and distribution partnerships across North America, Europe and Latin America. The company’s strategic acquisitions have bolstered its portfolio with mature prescription brands, while co‐promotion deals extend its reach into complementary therapeutic areas. Reviva’s lean organizational structure allows for rapid decision-making and focused resource allocation, supporting both product launches and life-cycle management activities.
Under the leadership of President and Chief Executive Officer Fredric A. Price, Reviva’s executive team combines decades of experience in specialty pharma, medical affairs and commercial operations. The board of directors and senior management team prioritize disciplined financial stewardship, timely regulatory filings and high-impact clinical programs. Looking ahead, Reviva aims to deepen its presence in core dermatology markets while exploring adjacent opportunities in aesthetic and wound-care applications.
